Article
When “Everything” Is the Pain Point
When “Everything” Is the Pain Point: Rethinking RTSM for Real-World Use
When RTSM creates more friction than confidence, even routine trial operations can become unnecessarily complex. From system updates and dosing flexibility to supply forecasting and fragmented data, study teams are navigating challenges that traditional, rigid RTSM approaches weren’t designed to solve.
This article explores how responsive RTSM design, operational expertise, and thoughtfully applied AI can help teams reduce complexity and turn data into more actionable insight.
What you’ll learn
- What’s behind some of the most common RTSM pain points
- How responsive design can reduce workflow inconsistencies and unnecessary complexity
- How AI can support smarter clinical supply and inventory strategies
- How real-time data can enable faster, more informed decisions
- Why scalable, adaptable RTSM architecture matters for modern clinical trials
Discover what it takes to move from rigid RTSM systems to more responsive, adaptable trial execution.
-
Accelerating Study Design Changes in an Actively Enrolling RTSM System
Challenges, Strategies, and Endpoint’s Innovative Approach In the fast-paced world of clinical trials, agility is no longer a luxury, it’s…
-
The FDA Just Rewrote the Rules for Clinical Trials. Here’s What It Means for RTSM.
Operation TrialBlazer is the agency’s most significant modernization push in years. For randomization and trial supply management, the implications go…
-
Why Legacy RTSM Systems Create Risk in Biosimilar Trials
Smarter Supply. Less Waste. Greater Control. ________________ Biosimilar development places sustained pressure on clinical supply teams to balance cost containment,…